Puma Biotechnology Statistics
Total Valuation
PBYI has a market cap or net worth of $300.17 million. The enterprise value is $231.19 million.
Important Dates
The last earnings date was Thursday, February 26, 2026, after market close.
| Earnings Date | Feb 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PBYI has 50.88 million shares outstanding. The number of shares has increased by 3.16% in one year.
| Current Share Class | 50.88M |
| Shares Outstanding | 50.88M |
| Shares Change (YoY) | +3.16% |
| Shares Change (QoQ) | +1.16% |
| Owned by Insiders (%) | 15.05% |
| Owned by Institutions (%) | 61.65% |
| Float | 39.01M |
Valuation Ratios
The trailing PE ratio is 9.67 and the forward PE ratio is 23.60.
| PE Ratio | 9.67 |
| Forward PE | 23.60 |
| PS Ratio | 1.31 |
| Forward PS | 1.40 |
| PB Ratio | 2.28 |
| P/TBV Ratio | 3.37 |
| P/FCF Ratio | 7.19 |
| P/OCF Ratio | 7.18 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 4.87, with an EV/FCF ratio of 5.54.
| EV / Earnings | 7.43 |
| EV / Sales | 1.01 |
| EV / EBITDA | 4.87 |
| EV / EBIT | 6.20 |
| EV / FCF | 5.54 |
Financial Position
The company has a current ratio of 2.00, with a Debt / Equity ratio of 0.22.
| Current Ratio | 2.00 |
| Quick Ratio | 1.86 |
| Debt / Equity | 0.22 |
| Debt / EBITDA | 0.56 |
| Debt / FCF | 0.68 |
| Interest Coverage | 5.63 |
Financial Efficiency
Return on equity (ROE) is 27.97% and return on invested capital (ROIC) is 52.61%.
| Return on Equity (ROE) | 27.97% |
| Return on Assets (ROA) | 10.85% |
| Return on Invested Capital (ROIC) | 52.61% |
| Return on Capital Employed (ROCE) | 27.62% |
| Weighted Average Cost of Capital (WACC) | 12.03% |
| Revenue Per Employee | $1.28M |
| Profits Per Employee | $173,804 |
| Employee Count | 179 |
| Asset Turnover | 1.06 |
| Inventory Turnover | 8.17 |
Taxes
In the past 12 months, PBYI has paid $4.67 million in taxes.
| Income Tax | 4.67M |
| Effective Tax Rate | 13.05% |
Stock Price Statistics
The stock price has increased by +67.61% in the last 52 weeks. The beta is 1.27, so PBYI's price volatility has been higher than the market average.
| Beta (5Y) | 1.27 |
| 52-Week Price Change | +67.61% |
| 50-Day Moving Average | 6.50 |
| 200-Day Moving Average | 5.05 |
| Relative Strength Index (RSI) | 41.15 |
| Average Volume (20 Days) | 497,026 |
Short Selling Information
The latest short interest is 3.66 million, so 7.20% of the outstanding shares have been sold short.
| Short Interest | 3.66M |
| Short Previous Month | 3.48M |
| Short % of Shares Out | 7.20% |
| Short % of Float | 9.39% |
| Short Ratio (days to cover) | 8.57 |
Income Statement
In the last 12 months, PBYI had revenue of $228.37 million and earned $31.11 million in profits. Earnings per share was $0.61.
| Revenue | 228.37M |
| Gross Profit | 170.21M |
| Operating Income | 37.30M |
| Pretax Income | 35.78M |
| Net Income | 31.11M |
| EBITDA | 47.44M |
| EBIT | 37.30M |
| Earnings Per Share (EPS) | $0.61 |
Full Income StatementBalance Sheet
The company has $97.53 million in cash and $28.55 million in debt, with a net cash position of $68.98 million or $1.36 per share.
| Cash & Cash Equivalents | 97.53M |
| Total Debt | 28.55M |
| Net Cash | 68.98M |
| Net Cash Per Share | $1.36 |
| Equity (Book Value) | 130.34M |
| Book Value Per Share | 2.59 |
| Working Capital | 81.43M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $41.80 million and capital expenditures -$71,000, giving a free cash flow of $41.73 million.
| Operating Cash Flow | 41.80M |
| Capital Expenditures | -71,000 |
| Free Cash Flow | 41.73M |
| FCF Per Share | $0.82 |
Full Cash Flow StatementMargins
Gross margin is 74.53%, with operating and profit margins of 16.33% and 13.62%.
| Gross Margin | 74.53% |
| Operating Margin | 16.33% |
| Pretax Margin | 15.67% |
| Profit Margin | 13.62% |
| EBITDA Margin | 20.77% |
| EBIT Margin | 16.33% |
| FCF Margin | 18.27% |
Dividends & Yields
PBYI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.16% |
| Shareholder Yield | -3.16% |
| Earnings Yield | 10.36% |
| FCF Yield | 13.90% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | -0.72% |
| EPS Growth Forecast (5Y) | -10.16% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PBYI has an Altman Z-Score of -4.84 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.84 |
| Piotroski F-Score | 7 |
